GRAMD1B
Basic information
Region (hg38): 11:123358428-123627774
Previous symbols: [ "LINC01059" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GRAMD1B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 29 | 37 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 3 | 1 | 4 | |||
non coding | 1 | |||||
Total | 0 | 0 | 29 | 10 | 6 |
Variants in GRAMD1B
This is a list of pathogenic ClinVar variants found in the GRAMD1B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-123577386-C-G | not specified | Uncertain significance (Dec 19, 2023) | ||
11-123577489-C-G | not specified | Uncertain significance (May 31, 2023) | ||
11-123577563-G-A | not specified | Uncertain significance (Jan 09, 2024) | ||
11-123584304-C-T | GRAMD1B-related disorder | Likely benign (Aug 07, 2019) | ||
11-123594078-G-A | GRAMD1B-related disorder | Benign (Jun 11, 2019) | ||
11-123594776-C-T | Intellectual disability | Likely pathogenic (-) | ||
11-123595994-G-T | not specified | Uncertain significance (Aug 04, 2021) | ||
11-123603537-A-G | not specified | Uncertain significance (Jul 20, 2022) | ||
11-123605357-T-C | not specified | Uncertain significance (Apr 11, 2023) | ||
11-123605383-A-G | not specified | Uncertain significance (Apr 15, 2024) | ||
11-123605400-T-A | Benign (Aug 08, 2017) | |||
11-123605469-C-T | Benign (Jan 05, 2018) | |||
11-123606637-C-T | not specified | Likely benign (May 06, 2024) | ||
11-123606644-G-A | GRAMD1B-related disorder | Benign (Oct 21, 2019) | ||
11-123606648-G-T | not specified | Uncertain significance (Oct 05, 2022) | ||
11-123606661-A-G | not specified | Uncertain significance (May 24, 2023) | ||
11-123606672-G-A | not specified | Uncertain significance (Dec 16, 2021) | ||
11-123606675-A-G | Likely benign (May 01, 2023) | |||
11-123606682-A-G | GRAMD1B-related disorder | Likely benign (Jun 24, 2019) | ||
11-123606742-A-G | not specified | Uncertain significance (Feb 23, 2023) | ||
11-123606750-G-A | not specified | Uncertain significance (May 11, 2022) | ||
11-123608664-G-A | GRAMD1B-related disorder | Likely benign (Aug 11, 2022) | ||
11-123608758-A-G | not specified | Uncertain significance (Jun 10, 2024) | ||
11-123608773-G-A | not specified | Uncertain significance (Oct 30, 2023) | ||
11-123608775-G-A | not specified | Uncertain significance (Dec 13, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GRAMD1B | protein_coding | protein_coding | ENST00000529750 | 20 | 102139 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.999 | 0.000713 | 124629 | 0 | 9 | 124638 | 0.0000361 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.23 | 249 | 440 | 0.566 | 0.0000270 | 4838 |
Missense in Polyphen | 60 | 149.89 | 0.4003 | 1584 | ||
Synonymous | -0.0143 | 176 | 176 | 1.00 | 0.0000120 | 1314 |
Loss of Function | 5.37 | 5 | 43.0 | 0.116 | 0.00000217 | 488 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000137 | 0.000129 |
Ashkenazi Jewish | 0.000104 | 0.0000994 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000447 | 0.0000442 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000332 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Pathway
- Ectoderm Differentiation
(Consensus)
Intolerance Scores
- loftool
- 0.353
- rvis_EVS
- -0.47
- rvis_percentile_EVS
- 23.51
Haploinsufficiency Scores
- pHI
- 0.393
- hipred
- Y
- hipred_score
- 0.755
- ghis
- 0.582
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.169
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gramd1b
- Phenotype
Gene ontology
- Biological process
- cholesterol transport;cholesterol homeostasis;cellular response to cholesterol;intermembrane sterol transfer
- Cellular component
- endoplasmic reticulum membrane;plasma membrane;membrane;integral component of membrane;endoplasmic reticulum-plasma membrane contact site
- Molecular function
- phosphatidylserine binding;cholesterol binding;phosphatidic acid binding;intermembrane cholesterol transfer activity